Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: Statistical considerations, design rationale, and challenges

enthalten in: Clinical trials | 2016

von Vandebosch, A. | Vangeneugden, T. | Goeyvaerts, N. | +6